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bodies. Membranes and immunoprecipitates w re also assayed for PI 
Abstract In rat adipocytes, phorbol ester-induced activation of 3-kinase activity as described [9] by incubation for 10 min in buffer 
PKC did not inhibit insulin signalling through IRS-l-dependent containing 8 mM Tris-HC1 (pH, 7.4), 100 mM NaC1, 3.3 mM EDTA, 
phosphatidylinositol (PI) 3-kinase activation. Moreover, phorbol 14 mM MgC12, 0.13 mM EGTA, 20 p.g/ml phosphatidylinositol, and 
esters alone provoked an increase in membrane PI  3-kinase 58 ~tM [7-32P]ATP (20 ~Ci; NEN). After incubation, 32P-labeled phos- 
phatidylinositol 3-phosphate was extracted into CHC13/CH3OH (2:1) 
activity. These findings may be relevant o the failure of phorbol and purified by thin-layer chromatography (TLC) [9]. Autoradio- 
esters to inhibit insulin effects on glucose transport and glycogen grams and immunoblots [developed by ECL (Amersham)] were quan- 
synthesis in rat adipocytes, titated by autoradiography and laser scanning densitometry. 
2-[3H]Deoxyglucose (2-DOG) uptake was measured (see [8]) by in- 
Key words." Insulin; Phorbol ester; Phosphatidylinositol cubation of cells for 30 min in glucose-free KRP with or without 500 
3-kinase; Glucose transport; Adipocyte; IRS-1 nM TPA and/or 10 nM insulin, as indicated, followed by addition of 
0.1 mM 2-[3H]DOG (1 ~tCi; NEN) and measurement of uptake over 
1 min. Glycogen synthesis was assessed by two methods: (a) as de- 
scribed [8] by measuring fractional activity of glycogen synthase [i.e. 
1. Introduction as assayed with or without 10 mM glucose 6-phosphate] in homoge- 
nates obtained from adipocytes incubated with or without 500 nM 
TPA and/or 10 nM insulin for 20 rain in KRP buffer containing 0 or 
Phorbol esters, like insulin, stimulate the phosphorylation 1 mM glucose; and (b) by incubating adipocytes for 30 rain in KRP 
of human insulin receptors in 3T3 fibroblasts [1] and CHO buffer containing 5 mM glucose and 2 ~tCi D-[U-14C]glucose (NEN), 
cells [2], but the consequences are uncertain. In CHO cells and measuring incorporation of label into glycogen by heating cell 
extracts in 4 N KOH at 100°C for 30 min and trapping lycogen on 
overexpressing protein kinase C-~ (PKC-~), phorbol esters filter papers which were washed with cold ethanol. 
inhibit insulin-induced activation of phosphatidylinositol 
(PI)-3 kinase without changes in insulin receptor kinase activ- 
ity, however, PI 3-kinase inhibition is not observed in untrans- 3. Results 
fected CHO cells containing normal PKC-c~ levels [3]. In rat 
adipocytes, phorbol esters inhibit insulin binding and tyrosine As shown in Figs. 1 and 2, the addition of 500 nM TPA 20 
kinase activity of purified insulin receptors [4], but have little rain before insulin failed to alter basal or insulin-induced in- 
[4,5] or no [6,7] effect on insulin-stimulated glucose transport creases in the co-immunoprecipitation of immunoreactive PI 
or glycogen synthase activation [8], processes that may require 3-kinase with either IRS-1 or total PY-containing proteins in 
PI 3-kinase activation [8,9]. Presently, we further examined total cell lysates of rat adipocytes. Similarly, insulin-induced 
the interacting effects of phorbol esters and insulin on PI 3- increases in PI 3-kinase nzyme activity in both c~-IRS-1 and 
kinase and subsequent metabolic processes in rat adipocytes, c~-PY immunoprecipitates were not diminished by TPA pre- 
treatment (Fig. 2). 
2. Materials and methods Since TPA failed to diminish IRS-l-dependent immunopre- 
cipitation and activation of PI 3-kinase, it was of interest o 
Adipocytes were prepared by collagenase digestion of rat epididy- determine whether insulin effects on overall tyrosine phos- 
real fat pads as described [9], equilibrated at 37°C in glucose-free phorylation of IRS-1 would be altered by TPA. Accordingly, 
Krebs Ringer phosphate (KRP) buffer containing 1% bovine serum 
albumin (BSA; Sigma), and treated for 10 min with vehicle or 500 nM as shown in Fig. 2, TPA failed to diminish insulin effects on 
tetradecanoyl phorbol-13-acetate (TPA; Sigma), followed by 300 nM tyrosine-phosphorylation of IRS-1. 
insulin (Elanco) for 15 min, unless indicated otherwise. After incuba- In addition to finding that insulin effects on overall IRS-1 
tion, membranes were obtained as described [9] by homogenization f tyrosine phosphorylation, and IRS-l-dependent PI 3-kinase 
cells in buffer A containing 20 mM Tris-HC1 (pH, 7.4), 5 mM EGTA, activation were not inhibited by TPA, we also surprisingly 
5 mM EDTA, 255 mM sucrose, 1 mM Na vanadate, 1 mM Na 
pyrophosphate, 1 mM NaF, 1 mM PMSF, 20 ~tg/ml aprotinin and found that TPA alone increased PI 3-kinase activity in adipo- 
20 I.tg/ml eupeptin, followed by centrifugation at 300000×g for 45 cyte membranes nearly as well as insulin (Fig. 3). 
min. Cell lysates were obtained by homogenization in buffer A con- Since TPA failed to inhibit insulin effects on IRS-l-depen- 
taining 150 mM NaC1, 1% Triton X-100 and 0.5% Nonidet, and then dent activation of PI 3-kinase, it was of interest o examine 
immunoprecipitated with antiphosphotyrosine (et-PY) monoclonal 
antibodies [Upstate Biotechnology Incorporated (UBI) or Transduc- the effects of TPA on metabolic processes that are wortman- 
tion Laboratories], or polyclonal a-IRS-1 antiserum (generously sup- nin-sensitive (and thus possibly PI 3-kinase-dependent) i  rat 
plied by Dr. Alan Saltiel). Immunoprecipitates w re subjected to SDS- adipocytes, viz. glucose transport and glycogen synthesis. As 
PAGE and immunoblotted with ct-PI 3-kinase (UBI) or ct-PY anti- shown in Fig. 4, TPA increased 2-DOG uptake modestly rel- 
ative to insulin, and, moreover, had no effect on: (a) insulin- 
*Corresponding author. Fax: (813)972-7623. stimulated 2-DOG uptake; (b) basal- or insulin-stimulated 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
PH S00 1 4 -5793(96)00492-9  
M.L. Standaert et aI./FEBS Letters 388 (1996) 26~8 27 
t ~ ~  [ ~ ]  hibitory effect of TPA on PI 3-kinase activation observed in 
CHO cells overexpressing PKC-cc [3] may not be relevant to 
* , adipose and muscle tissues of intact rodents. 
250 * 250 _L  The failure of TPA to inhibit glycogen synthesis in rat adi- 
..z_. I pocytes contrasts with inhibition observed in rat skeletal mus- 
20o ~ 2oo] cle ([14]; also confirmed in our laboratory) and liver [15]. The 
15o ~ 15o reason for this difference is uncertain. However, in view of the 
,~ ,~ present and previous [10-13] findings, the inhibitory effects of 
loo . .L. loo r- L TPA on glycogen synthesis in muscle and liver may be pro- 
[ voked through mechanisms independent of IRS-l-dependent 
50 50 / PI 3-kinase activation, perhaps by phosphorylation f distal 
0 0 regulatory factors and/or glycogen synthase itself. 
INS - + - + INS + - The stimulatory effect of TPA on adipocyte membrane PI
TPA ÷ + TPA ÷ 3-kinase activity is of interest, as it has also been noted in 
Fig. 1. Effects of TPA and insulin on levels of immunoreactive PI platelets [16] and 3T3/L1 adipocytes [17], and such cross- 
3-kinase in et-IRS-1 (left) and ct-PY (right) immunoprecipitates, talk between PKC and PI 3-kinase has many implications. 
Representative immunoblots of the p85 subunit of PI 3-kinase are In 3T3/L1 adipocytes, TPA-induced activation of PI 3-kinase 
shown in insets. Bars depict mean + S.E.M. results of densitometric may explain how TPA stimulates glucose transport, as this 
scans of 3-5 experiments with the control set at 100%. Asterisk in- 
dicates p< 0.05 (paired t-test), effect of TPA, like that of insulin, is blocked by wortmannin 
([17]; also confirmed in our laboratory). This explanation, 
however, is not applicable to the rat adipocyte, wherein 
[U-14C]glucose incorporation i to glycogen, or (c) basal or TPA effects on glycose transport are not inhibited by wort- 
insulin-stimulated glycogen synthase activity (later data not mannin [18], and PKC, apparently in its own right, activates 
shown, but see [9]). glucose transport. With respect o glycogen synthase, the fail- 
ure of TPA to stimulate its activity suggests that simple in- 
4. Discussion creases in membrane PI 3-kinase activity may not be sufficient 
to activate glycogen synthase. 
Although insulin receptor tyrosine kinase is inhibited by The mechanism whereby TPA activates PI 3-kinase in adi- 
TPA in certain circumstances, we presently found in rat adi- pocyte membranes is presently unclear; however, it is unlikely 
pocytes that TPA had relatively little or no effect on both that PKC contributes importantly to insulin effects on mem- 
insulin signalling through IRS-l-dependent PI 3-kinase activa- brane PI 3-kinase. Indeed, in the rat adipocyte, the major 
tion, and subsequent activation of putative downstream eta- effects of insulin on PKC appear to be downstream of PI 3- 
bolic processes, viz. glucose transport and glycogen synthesis, kinase, which seems to be important for activation of a phos- 
Effects of TPA and PKC on this signalling system in other cell pholipase D that hydrolyzes phosphatidylcholine  the plas- 
types are not entirely clear, but in rodent skeletal muscles, ma membrane [18], and increases D 3-phosphate derivatives 
both TPA-induced [10,11] and denervation-induced [12,13] of PI, which in turn, activate PKC. Further studies will be 
PKC activation do not inhibit insulin-induced activation of 
insulin receptor tyrosine kinase or PI 3-kinase. Thus, the in- 
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Fig. 2. (A) Effects of TPA on insulin-induced increases in PI 3-ki- 
nase levels (A, top) and PY content of IRS-1 (A, bottom) in cc-IRS- Fig. 3. Activation of PI 3-kinase in membranes of rat adipocytes 
1 immunoprecipitates, and (B) PI 3-kinase nzyme activity in c~- treated for 15 min with TPA or insulin. A representative autoradio- 
IRS-I immunoprecipitates (B, top) and ct-PY immunoprecipitates gram is shown at the left, and mean__. S.E.M. results of 5 experi- 
(B, bottom). 1B designates immunoblots developed with c~-PI-3 ki- ments are shown to the right. Asterisk indicates p<0.05 (paired t- 
nase and ct-PY antibodies, test). 
m 
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needed to determine how TPA increases membrane PI 3-ki- 
nase activity in rat adipocytes. 
2 Acknowledgements." This material is based upon work supported by 
the Office of Research and Development, Medical Research Service, 
Department of Veterans' Affairs; and by the National Institutes of w~ 
O • Health Grant DK 38079. 
-i -! 
~"  References 
o0,- 1 
X [1] Lewis, R.E., Cao, L., Perregaux, D. and Czech, M.P. (1990) 
Biochemistry 29, 1807-1813. 
~: [2] Ahn, J., Donner, D.B. and Rosen, O.M. (1993) J. Biol. Chem. 
~,~ O~ 268, 7571-7576. 
[3] Chin, J.E., Dickens, M., Tavare, J.M. and Roth, R.A. (1993) 
J. Biol. Chem. 268, 6338-6347. 
0 [4] Haring, H., Kirsch, D., Obermaier, B., Ermel, B. and Machicao, 
INS 0 0 + + F. (1986) J. Biol. Chem. 261, 3869-3875. 
TPA 0 + 0 + [5] Cherqui, G., Caron, M., Wicek, D., Lascols, O., Capeau, J. and 
Pciard, J. (1986) Endocrinology 118, 1759-1768. 
[6] Saltis, J., Habberfield, A.D., Egan, J.J., Londos, C., Simpson, 
I.A. and Cushman, S.W. (1991) J. Biol. Chem. 266, 261-267. 
[7] Farese, R.V., Standaert, M., Yu, B., Hernandez, H. and Cooper, 
D.R. (1993) J. Biol. Chem. 268, 19949-19955. 
[8] Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O. and Ui, M. 
O~ 16"  (1994) J. Biol. Chem. 269, 3568-3573. 
O "-" [9] Standaert, M.L., Bandyopadhyay, G. and Farese, R.V. (1995) 
._~ .~ Biochem. Biophys. Res. Commun. 209, 1082-1088. 
= 12 [10] Guma, A., Camps, M., Palacin, M., Testar, X. and Zorzano, A. 
t ~ (1990) Biochem. J. 268, 633-639. 
O~O [11] Tanti, J.F., Gremeaux, T., Van Obberghen, E. and Marchand- 
Brustel, Y.L. (1994) J. Biol. Chem. 269, 6051-6057. 
O X 8 [12] Burant, C.F., Treutelaar, M.K. and Buse, M.G. (1986) J. Biol. 
E ! Chem. 261, 8985-8993. 
~---,~ ! [13] Chen, K.S., Friel, J.C. and Ruderman, N.B. (1993) Am. J. Phys- 
(9 ~ iol. 265, E736-742. 
4 .... . . . . . . . . .  [14] Sowell, M.O., Treutelaar, M.K., Burant, C.F. and Buse, M.G. 
-- (1988) Diabetes 37, 499-506. 
0 [15] Quentmeier, A., Daneschmand, H., Klein, H., Unthan-Fechner, 
K. and Probst, I. (1993) Biochem. J. 289, 549-555. 
INS 0 0 + + [16] King, W.O., Kucera, G.L., Sorisky, A., Zhang, J. and Ritten- 
TPA 0 + 0 + house, S.E. (1991) Biochem. J. 278, 475-480. 
[17] Nave, B.T., Shepherd, P.R. and Siddle, K. (1995) Biochem. Soc. 
Fig. 4. Effects of TPA on control and insulin-stimulated 2- Trans. 23, 183S. 
[aH]deoxyglucose uptake (top) and [14C]glucose incorporation i to [18] Standaert, M.L., Avignon, A., Yamada, K., Bandyopadhyay, G. 
glycogen (bottom). Values are mean + S.E.M. of 4 determinations, and Farese, R.V. (1996) Biochem. J. 313, 1039-1046. 
